Bill Kristol @BillKristol
“Will the FDA authorization of COVID-related medications now be viewed as driven by the president, based on his political needs, rather than by the medical researchers evaluating the data? This would dramatically lower the credibility of the agency...” https://t.co/MyDtSo5CMj — PolitiTweet.org